Jun Yoshino

Physiology · 2005–2017

A researcher in the Science corpus: 7 papers; trusts 10 researchers and is trusted by 2 researchers here, as inferred from the citation graph.

Subfields

• Physiology — 59 citations into it; #1,403 of 2,276 by trust here, #765 by citations
• Geriatrics and Gerontology — 45 citations into it; #77 of 114 by trust here, #68 by citations
• Epidemiology — 37 citations into it
• Molecular Biology — 21 citations into it
• Oncology — 16 citations into it
• Genetics — 12 citations into it

Whom Jun Yoshino trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

1. C. Cantó
2. K. Mills
3. Seon-Young Kim
4. S. Imai
5. Javier R. Revollo
6. S. Shoelson
7. Kevin J. Bitterman
8. Evandro Fei Fang
9. Keir J. Menzies
10. Andrew A. Grimm

Who trusts Jun Yoshino overall

1. C. Cantó
2. R. Houtkooper
3. S. Imai
4. Catherine Lebel
5. Joseph A. Baur
6. K. Mills
7. E. Verdin
8. Hung-Chun Chang
9. Jacques-Donald Tournier
10. W. Kaelin

Papers from Jun Yoshino's perspective

Ordered by how strongly the researchers Jun Yoshino trusts endorse each paper. Same corpus, a different order for every researcher.

1. Nicotinamide mononucleotide, a key NAD+ intermediate, treats the pathophysiology of diet- and age-induced diabetes in mice (Cell Metabolism)
2. The NAD Biosynthesis Pathway Mediated by Nicotinamide Phosphoribosyltransferase Regulates Sir2 Activity in Mammalian Cells* (Journal of Biological Chemistry)
3. Mitonuclear protein imbalance as a conserved longevity mechanism (Nature)
4. Glucose restriction inhibits skeletal myoblast differentiation by activating SIRT1 through AMPK-mediated regulation of Nampt. (Developmental Cell)
5. FK866, a highly specific noncompetitive inhibitor of nicotinamide phosphoribosyltransferase, represents a novel mechanism for induction of tumor cell apoptosis. (Cancer Research)
6. Interdependence of AMPK and SIRT1 for metabolic adaptation to fasting and exercise in skeletal muscle (Cell Metabolism)
7. Circadian Clock Feedback Cycle Through NAMPT-Mediated NAD+ Biosynthesis (Science)
8. Inhibition of Silencing and Accelerated Aging by Nicotinamide, a Putative Negative Regulator of Yeast Sir2 and Human SIRT1* (Journal of Biological Chemistry)
9. Nampt/PBEF/Visfatin regulates insulin secretion in beta cells as a systemic NAD biosynthetic enzyme. (Cell Metabolism)
10. Age Related Changes in NAD+ Metabolism Oxidative Stress and Sirt1 Activity in Wistar Rats (PLoS ONE)

Their papers

• NAD+ intermediates: The biology and therapeutic potential of NMN and NR (2017) — 930 citations
• Effects of Moderate and Subsequent Progressive Weight Loss on Metabolic Function and Adipose Tissue Biology in Humans with Obesity. (2016) — 797 citations
• Long-term administration of nicotinamide mononucleotide mitigates age-associated physiological decline in mice (2016) — 803 citations
• Nicotinamide mononucleotide, a key NAD+ intermediate, treats the pathophysiology of diet- and age-induced diabetes in mice (2011) — 1,291 citations
• Circadian Clock Feedback Cycle Through NAMPT-Mediated NAD+ Biosynthesis (2009) — 1,093 citations
• Targeting autophagy potentiates tyrosine kinase inhibitor-induced cell death in Philadelphia chromosome-positive cells, including primary CML stem cells. (2009) — 605 citations
• Demyelination increases radial diffusivity in corpus callosum of mouse brain (2005) — 1,710 citations